Please assess the completion status of the following clinical trial:

Trial Title: Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 18 years or older~* ICU admission for more than 3 days~* Admission for septic shock~* Patient with mechanical invasive ventilation~Exclusion Criteria:~* Immunodepression status before ICU admission (chemotherapy, bone marrow or solid organ transplantation, long time corticosteroid treatment, immunosuppressant therapy, HIV infection)~* Seronegative patient for CMV~* Patient under anti-virus treatment~* Patient under guardianship

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Septic shock patients (Type: None): Septic shock patients staying over 3 days mechanically ventilated in the ICU

Based on this trial design, predict the completion outcome and termination type (if applicable).